1. Home
  2. Mandates
  3. Vinge advises Investor Growth Capital

Mandate Vinge advises Investor Growth Capital

January 30, 2009

Vinge has advised Investor Growth Capital in connection with its investment in Synosia Therapeutics. Synosia Therapeutics is a company which develops and intends to commercialise innovative and clinically differentiated products for unfulfilled medical requirements within psychiatry and neurology.
 
Vinge’s team consisted of responsible partner Johan Winnerblad together with associate Karl Svantema.

Vinge is awarded “The Top Firm in Sweden” in WTR 1000’s latest ranking

 Vinge receives the highest ranking in the World Trademark Review list of the year’s rankings. The firm obtains the Guide’s foremost ranking, which also highlights specific experts.
February 18, 2021

Insurance services in Sweden – a summary 2021

 Vinge’s insurance team has written a brief summary of some of the main features of the Swedish regulations affecting foreign insurers with existing or contemplated business activities in Sweden.
February 09, 2021

Summary of employment related news in Sweden as of January 2021

 Short-time work, a new pandemic law and pending changes to the Employment Protection Act. Here is the latest employment related news in Sweden.
January 19, 2021